Renal Disease Research Institute (RDRI) is a research entity affiliated with Dallas Nephrology Associates. For over 45 years, Dallas Nephrology Associates has been caring for patients with kidney disease, hypertension, transplants and complicated electrolyte disorders. The Research Institute allows us to conduct clinical trials that will improve our future ability to treat kidney disease and give our patients the opportunity to receive cutting edge therapy. At RDRI, there is significant ethical oversight of this entity through RDRI’s Board of Managers and Scientific Review Committee.
Choosing to participate in a study is an important personal decision. Are you interested in participating in a study? Talk with your doctor and family members or friends about deciding to join a study.
We are currently enrolling patients with the following conditions:
- Alport Syndrome
- Chronic Kidney Disease (CKD) with Anemia – Non-dialysis
- Chronic Kidney Disease (CKD) with Anemia – Dialysis
- Focal segmental glomerulosclerosis (FSGS)